BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1054 related articles for article (PubMed ID: 20851627)

  • 41. Clinical diffusion mismatch better discriminates infarct growth than mean transit time-diffusion weighted imaging mismatch in patients with middle cerebral artery-M1 occlusion and limited infarct core.
    Nogueira RG; Kemmling A; Souza LM; Payabvash S; Hirsch JA; Yoo AJ; Lev MH
    J Neurointerv Surg; 2017 Feb; 9(2):127-130. PubMed ID: 26957483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early recanalization rate of major occluded brain arteries after intravenous tissue plasminogen activator therapy using serial magnetic resonance angiography studies.
    Kimura K; Iguchi Y; Shibazaki K; Aoki J; Uemura J
    Eur Neurol; 2009; 62(5):287-92. PubMed ID: 19713704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
    Matsuzaki T; Yoshino A; Sakatani K; Katayama Y
    J Stroke Cerebrovasc Dis; 2011; 20(3):269-72. PubMed ID: 20630773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential patterns of evolution in acute middle cerebral artery infarction with perfusion-diffusion mismatch: atherosclerotic vs. cardioembolic occlusion.
    Kim HJ; Yun SC; Cho KH; Cho AH; Kwon SU; Kim JS; Kang DW
    J Neurol Sci; 2008 Oct; 273(1-2):93-8. PubMed ID: 18692854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
    Kimura K; Iguchi Y; Yamashita S; Shibazaki K; Kobayashi K; Inoue T
    J Neurol Sci; 2008 Apr; 267(1-2):57-61. PubMed ID: 17964602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion.
    Lansberg MG; Thijs VN; Bammer R; Olivot JM; Marks MP; Wechsler LR; Kemp S; Albers GW
    Stroke; 2008 Sep; 39(9):2491-6. PubMed ID: 18635861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early ischaemic diffusion lesion reduction in patients treated with intravenous tissue plasminogen activator: infrequent, but significantly associated with recanalization.
    Sakamoto Y; Kimura K; Shibazaki K; Inoue T; Uemura J; Aoki J; Sakai K; Iguchi Y
    Int J Stroke; 2013 Jul; 8(5):321-6. PubMed ID: 23013151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study.
    Neumann-Haefelin T; du Mesnil de Rochemont R; Fiebach JB; Gass A; Nolte C; Kucinski T; Rother J; Siebler M; Singer OC; Szabo K; Villringer A; Schellinger PD;
    Stroke; 2004 Jan; 35(1):109-14. PubMed ID: 14671246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment outcomes of tissue plasminogen activator infusion for branch atheromatous disease.
    Deguchi I; Hayashi T; Kato Y; Nagoya H; Ohe Y; Fukuoka T; Maruyama H; Horiuchi Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e168-72. PubMed ID: 23246192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke.
    Nakashima T; Toyoda K; Koga M; Matsuoka H; Nagatsuka K; Takada T; Naritomi H; Minematsu K
    Int J Stroke; 2009 Dec; 4(6):425-31. PubMed ID: 19930051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging.
    Kidwell CS; Saver JL; Mattiello J; Starkman S; Vinuela F; Duckwiler G; Gobin YP; Jahan R; Vespa P; Kalafut M; Alger JR
    Ann Neurol; 2000 Apr; 47(4):462-9. PubMed ID: 10762157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patients with diffusion-perfusion mismatch on magnetic resonance imaging 48 hours or more after stroke symptom onset: clinical and imaging features.
    Perez A; Restrepo L; Kleinman JT; Barker P; Beauchamp N; Wityk RJ
    J Neuroimaging; 2006 Oct; 16(4):329-33. PubMed ID: 17032382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CTP infarct core may predict poor outcome in stroke patients treated with IV t-PA.
    Wu TC; Sitton C; Potter A; Bowry R; Sahota P; Cai C; Hui P; Chen Z; Gonzales N; Barreto A; Lopez G; Grotta JC; Savitz SI
    J Neurol Sci; 2014 May; 340(1-2):165-9. PubMed ID: 24694764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early magnetic resonance imaging prediction of arterial recanalization and late infarct volume in acute carotid artery stroke.
    Hermier M; Nighoghossian N; Adeleine P; Berthezène Y; Derex L; Yilmaz H; Dugor JF; Dardel P; Cotton F; Philippeau F; Trouillas P; Froment JC
    J Cereb Blood Flow Metab; 2003 Feb; 23(2):240-8. PubMed ID: 12571455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnetic resonance imaging investigation of secondary degeneration of the mesencephalic substantia nigra after cerebral infarction.
    Ohe Y; Uchino A; Horiuchi Y; Maruyama H; Deguchi I; Fukuoka T; Kato Y; Nagoya H; Dembo T; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):58-65. PubMed ID: 21784662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluid-Attenuated Inversion Recovery Vascular Hyperintensities-Diffusion-Weighted Imaging Mismatch Identifies Acute Stroke Patients Most Likely to Benefit From Recanalization.
    Legrand L; Tisserand M; Turc G; Edjlali M; Calvet D; Trystram D; Roca P; Naggara O; Mas JL; Méder JF; Baron JC; Oppenheim C
    Stroke; 2016 Feb; 47(2):424-7. PubMed ID: 26732567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of small vessel disease in re-exacerbation of stroke symptoms within 24 hours after tissue plasminogen activator infusion.
    Uemura J; Kimura K; Inoue T; Shibazaki K; Sakamoto Y; Aoki J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):75-9. PubMed ID: 23153551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
    Kim DH; Lee DS; Nah HW; Cha JK
    BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Presence of deep white matter lesions on diffusion-weighted imaging is a negative predictor of early dramatic improvement after intravenous tissue plasminogen activator thrombolysis.
    Kawano H; Hirano T; Inatomi Y; Terasaki T; Yonehara T; Uchino M
    Cerebrovasc Dis; 2010 Aug; 30(3):230-6. PubMed ID: 20606424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.